Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Colorectal Neoplasms 44Colonic Neoplasms 17Colonic Polyps 12Adenoma 8Polyps 4Gastrointestinal Neoplasms 3Colorectal Neoplasms, Hereditary Nonpolyposis 3Adenomatous Polyps 3Rectal Neoplasms 2Neoplasms 2Intestinal Neoplasms 2Stomach Neoplasms 1Rectal Diseases 1Peptic Ulcer 1Patient Satisfaction 1Obesity 1Non-alcoholic Fatty Liver Disease 1Neoplasms by Site 1Neoplasms by Histologic Type 1Metabolic Syndrome 1Liver Cirrhosis 1Irritable Bowel Syndrome 1Intestinal Diseases 1Hyperplasia 1Gastrointestinal Hemorrhage 1Gastrointestinal Diseases 1Gastritis, Atrophic 1Diverticulitis, Colonic 1Diverticulitis 1Disease 1

Interventions

Endoscopy 2Eicosapentaenoic Acid 2pegvisomant 1Restraint, Physical 1Microspheres 1Colonoscopy 1Clinical Chemistry Tests 1Cholecalciferol 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hyperplasia × Colonoscopy × Clear all
NCT00432913 2008-10-17

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

S.L.A. Pharma AG

Phase 2/3 Completed
120 enrolled

Hyperplasia, Polyps, Adenomatous Polyps

Data powered by HemOnc (CC BY 4.0) Colophon âš¡